The role of concomitant immunosuppressants in impeding the progression of diabetic retinopathy: A pilot study.
PURPOSE: Hallmark of Diabetic Retinopathy (DR) is blood-retinal barrier alteration. Vascular endothelial growth factor (VEGF) and inflammation are involved in the pathogenesis of DR. Anti-VEGFs and lasers are effective in treating DR but have numerous dra..... Read More